dihexa transdermal Peptide Dihexa · Disguised Alpha

BPC-157 is most commonly administered via a small subcutaneous injection, which is quick, virtually painless, and easy to manage at home

Limited long-term data: most evidence is from animal models, with no long-term human study of NNMT inhibition and oncological endpoints

The therapeutic window is 1025mg/mL for most research peptides, including 5-Amino-1MQ

easy, convenient, and hassle-free

While formal clinical trials in humans are limited and the compound is not FDA-approved, early preclinical studies and anecdotal reports suggest it may play a role in supporting the body's natural healing processes

It can enlarge shrunken hair follicles, extend the hair growth phase, and improve overall scalp health